Role of Cytosorb in Left Ventricular Assist Device Implantation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Role of Cytosorb in Left Ventricular Assist Device Implantation — Stella

Home/Heart Failure/

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Harefield Hospital, Harefield

Key details

Sponsor

Imperial College London

Collaborators

UMC Utrecht, CytoSorbents, Inc

Enrollment target

~60 participants

Started

September 2020

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.